A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)-Reference-Cited by-同舟云学术

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Published:2012-07 Issue:1 Volume:77 Page:97-103
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

LeCaer H.,Greillier L.,Corre R.,Jullian H.,Crequit J.,Falchero L.,Dujon C.,Berard H.,Vergnenegre A.,Chouaid C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology(SIOG): experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population;Pallis;Ann Oncol,2010

2. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group;Jatoi;J Clin Oncol,2005

3. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES 2P studies;Gridelli;J Clin Oncol,2007

4. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer;Elderly Lung Cancer Vinorelbine Italian Study Group;J Natl Cancer Inst,1999

5. Non small-cell lung cancer in the elderly-the legacy of therapeutic neglect;Weiss;Curr Treat Options Oncol,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group;Journal of Thoracic Disease;2017-10

3. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al;Journal of Clinical Oncology;2016-11-20

4. Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer—A Systematic Review;Clinical Lung Cancer;2016-09

5. Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study;Journal of Clinical Oncology;2016-05-01